Skip to main content

Table 3 Cytotoxicity of L-OHP on OCUM-2MD3/L-OHP (μg/mL, %, x ¯ ± S, 24 h).

From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

Group

600

300

150

75

37.5

IC50

OCUM-2MD3

76.2 ± 1.1

69.3 ± 2.3

57.7 ± 1.3

44.2 ± 0.9

28.3 ± 2.6

111.3

OCUM-2MD3/L-OHP

60.6 ± 0.5*

42.6 ± 1.3*

35.5 ± 4.2*

19.9 ± 1.7*

6.4 ± 2.1*

354.4

  1. *Compared with OCUM-2MD3 Group P < 0.05
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us